Cybin Initiates First-in-Human Dosing of CYB004 in Phase 1 Clinical Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/15/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

Go back to Cybin Initiates First-in-Human Dosing of CYB004 in Phase 1 Clinical Trial
(NYSE: CYBN) Delayed: 8.28 --0 (-0%)
Previous Close $8.28    52 Week High $ 
Open $8.28    52 Week Low $ 
Day High $8.28    P/E N/A 
Day Low $8.28    EPS $ 
Volume 1,865,554       

(NYSE: CYBN) Delayed: 8.28 --0 (-0%)
Previous Close $8.28    52 Week High $ 
Open $8.28    52 Week Low $ 
Day High $8.28    P/E N/A 
Day Low $8.28    EPS $ 
Volume 1,865,554